Article

Pain-Drug Craving Not Linked With Risk of Misuse

Patients who are receiving opioid analgesics for chronic pain but are not substance-dependent or addicted often experience cravings to take more medication, according to researchers from the Harvard Medical School.

Patients who are receiving opioid analgesics for chronic pain but are not substance-dependent or addicted often experience cravings to take more medication, according to researchers from the Harvard Medical School. However, the cravings are not associated with pain levels or spikes in pain intensity.

The researchers evaluated self-reports of cravings in 62 patients for whom opioid analgesic medications were prescribed and who were at low or high risk for medication misuse to determine whether craving is associated with the desire to take more opioids, preoccupations with the next scheduled dose, and mood changes. They hypothesized that craving reports would be reduced through frequent patient monitoring and motivational counseling. The patients were seen monthly, completed electronic diaries, were given urine drug tests, and had monthly contact with their physicians.

The patients who were receiving opioids but were not dependent or addicted experienced drug cravings. Levels of craving were weakly associated with current levels of pain or average pain over 24 hours.

The authors concluded that craving is a mental experience distinct from pain and that craving is a common experience with opioid therapy that may not be related to substance abuse disorders and a higher risk for drug misuse. They noted that further studies are needed to determine whether craving is a useful indicator for eventual development of drug dependence or addiction. The research was reported in The Journal of Pain, a journal of the American Pain Society.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.